ZENTALIS PHARMACEUTICALS INC's ticker is and the CUSIP is 98943L907. A total of 4 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $154,530 | -67.5% | 10,200 | -57.0% | 0.00% | – |
Q3 2023 | $475,422 | -33.6% | 23,700 | -6.7% | 0.00% | – |
Q2 2023 | $716,534 | +154.0% | 25,400 | +54.9% | 0.00% | – |
Q1 2023 | $282,080 | -33.9% | 16,400 | -16.8% | 0.00% | – |
Q3 2022 | $427,000 | +50.4% | 19,700 | +95.0% | 0.00% | – |
Q2 2022 | $284,000 | – | 10,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
SIMPLEX TRADING, LLC | 4,100 | $115,000 | 0.00% |
GROUP ONE TRADING, L.P. | 600 | $17,000 | 0.00% |
JANE STREET GROUP, LLC | 10,100 | $284,000 | 0.00% |